Holley (US:HLLY)2026-03-04 14:30Financial Data and Key Metrics Changes - For the first time since 2021, the company achieved full-year net sales growth of $613.5 million, representing a 1.9% increase compared to fiscal 2024, with core net sales growth of 6.6% driven by 3.8% volume growth and 2.8% from pricing [29][30] - Adjusted EBITDA margins exceeded 20% for the first time since 2021, with adjusted EBITDA for the year reaching $124 million, up $13.5 million from 2024 [20][31] - Fourth quarter net sales increased by 10.9% year-over-year to $155.4 million, with core growth of 13.5%, marking the strongest core growth performance of 2025 [9][24] Business Line Data and Key Metrics Changes - The American Performance division saw a 10% year-over-year increase, while Truck & Off-Road grew by 5.4%, Euro & Import increased by 21.5%, and Safety & Racing rose by 13.3% [12] - New product launches contributed approximately $23 million in sales for the full year, highlighting the ongoing vitality of the company's portfolio [10] Market Data and Key Metrics Changes - The company reported that market growth in 2025 was approximately 3%-4%, with the company continuing to gain market share [38] - The Euro & Import segment, which caters to more affluent consumers, experienced significant double-digit growth, indicating a trend where higher-income consumers are less sensitive to economic pressures [58] Company Strategy and Development Direction - The company is focused on three strategic priorities: fueling teammates, strengthening customer relationships, and accelerating profitable growth, which guide capital allocation and performance measurement [13] - Plans for 2026 include expanding the performance chemicals portfolio, enhancing digital merchandising, and pursuing strategic M&A opportunities to strengthen growth categories [18][33] Management's Comments on Operating Environment and Future Outlook - The management noted that the consumer backdrop remains uneven, with middle and lower-income households facing pressure, while higher-income consumers are willing to spend [32] - The company expects revenue growth in 2026 to be in the range of $625 million to $655 million, implying approximately 4%-4.5% growth at the midpoint [32] Other Important Information - The company generated $34.2 million in free cash flow for the year, marking the third consecutive year of positive cash generation [27] - The company prepaid an additional $10 million of debt in Q4, bringing total prepayments to $100 million since September 2023, ending the year with leverage below 3.8x [9][20] Q&A Session Summary Question: Can you quantify market growth in 2025 and expectations for 2026? - Management indicated that market growth was around 3%-4% in 2025, with expectations for continued share gains in 2026, albeit at a slower pace [38] Question: What is the timing and frequency of pricing increases? - Management noted that pricing increases typically occur mid-year, with a modest price increase taken at the beginning of the year, but no significant increases anticipated for 2026 [40][41] Question: How does the company view elasticity and unit trends in relation to tariffs? - Management acknowledged some volume implications due to tariffs but emphasized a focus on surgical pricing actions to maintain margins and free cash flow [47] Question: Are any segments of the business more cyclical than others? - Management highlighted that the Euro & Import segment, catering to affluent consumers, showed robust growth, while overall health across the portfolio was noted [58] Question: Can you provide details on the ERP and WMS system implementation? - Management stated that 2026 will primarily focus on preparation for the ERP and WMS systems, with a go-live expected in early 2027 [67]